Abrogation of USP7 is an alternative strategy to downregulate PD-L1 and sensitize gastric cancer cells to T cells killing

Publication date: Available online 16 November 2020Source: Acta Pharmaceutica Sinica BAuthor(s): Zhiru Wang, Wenting Kang, Ouwen Li, Fengyu Qi, Junwei Wang, Yinghua You, Pengxing He, Zhenhe Suo, Yichao Zheng, Hongmin Liu
Source: Acta Pharmaceutica Sinica B - Category: Cancer & Oncology Source Type: research